Search Results - "RM Ribeiro"

RISK FACTORS'IMPACT ON THE OVERALL SURVIVAL OF ACUTE LYMPHOBLASTIC LEUKEMIA ADULT PATIENTS IN FORTALEZA by FMCP Pessoa, DS Oliveira, CB Machado, IV Barreto, BMD Nogueira, RM Ribeiro, FAC Silva, MOM Filho, MEA Moraes, CA Moreira-Nunes

“…Acute Lymphoblastic Leukemia (ALL) is a hematological neoplasm characterized by clonal proliferation of lymphoblasts, being one of the most common types of…”
Get full text

EVALUATING TREATMENT TIMELINES AND SURVIVAL OUTCOMES FOR PRIMARY CNS LYMPHOMA: A CROSS-SECTIONAL EVALUATION by ACC Farias, FET Filho, IL Pontes, LA Gurgel, FAC Silva, DS Oliveira, RM Ribeiro, RS Andrade

“…Objectives: This study assesses clinical outcomes for primary central nervous system lymphoma (PCNSL) patients, particularly focusing on the timelines from…”
Get full text

IMPACT OF PRE-TREATMENT TRANSFUSIONS ON CLINICAL PARAMETERS AND OUTCOMES IN APLASTIC ANAEMIA PATIENTS RECEIVING IMMUNOSUPPRESSIVE THERAPY by FET Filho, IL Pontes, ACC Farias, LA Gurgel, FAC Silva, DS Oliveira, RM Ribeiro, RS Andrade

“…Objectives: This study aims to compare clinical parameters and outcomes between patients with aplastic anaemia undergoing immunosuppressive treatment (IST) who…”
Get full text

CLINICAL HETEROGENEITY AND IMPACT OF TREATMENT INITIATION TIME IN NON-HODGKIN LYMPHOMA by FET Filho, ACC Farias, IL Pontes, FAC Silva, LA Gurgel, RM Ribeiro, RS Andrade, DS Oliveira

“…Objectives: This study aimed to analyze the clinical presentation of non-Hodgkin lymphoma (NHL) patients, focusing on age distribution, time to treatment…”
Get full text

QUANTITATIVE RT-QPCR BCR::ABL1 AT DIAGNOSIS OF CHRONIC MYELOID LEUKEMIA: A POPULATIONAL DECAYING ANALYSIS by DS Oliveira, FMCP Pessoa, FAC Silva, LM Albuquerque, PHM Alencar, LA Gurgel, RM Ribeiro, MOM Filho, MEA Moraes, CA Moreira-Nunes

“…Evaluate how TKIs affect the population dynamics of leukemic cells during treatment according an populational decaying model, with the goal of optimizing…”
Get full text

CLINICAL CHARACTERISTICS AND PROGNOSIS OF ACUTE PROMYELOCYTIC LEUKEMIA PATIENTS IN FORTALEZA by FMCP Pessoa, DS Oliveira, IV Barreto, PHM Alencar, KMC Albuquerque, RM Ribeiro, MP Gomes, MOM Filho, MEA Moraes, CA Moreira-Nunes

“…Acute Promyelocytic Leukemia (APL) is a specific and highly curable form of acute myeloid leukemia, characterized by the translocation t(15; 17) which results…”
Get full text

CLINICAL PROFILE AND SURVIVAL IN PATIENTS WITH HIGH-GRADE NON-HODGKIN LYMPHOMA by ACC Farias, FET Filho, IL Pontes, LA Gurgel, FAC Silva, RM Ribeiro, DS Oliveira, RS Andrade

“…Objectives: This study aims to compare clinical parameters and outcomes between patients with high grade non-Hodgkin lymphomas undergoing intensive…”
Get full text

IMPACT OF HIGH-RISK CYTOGENETICS ON THE SURVIVAL OF NON-APL ACUTE MYELOID LEUKEMIA PATIENTS by FMCP Pessoa, DS Oliveira, IV Barreto, AKC Machado, BMD Nogueira, CB Machado, RM Ribeiro, MOM Filho, MEA Moraes, CA Moreira-Nunes

“…Acute myeloid leukemia (AML) is a hematologic malignancy characterized by the rapid proliferation of abnormal myeloid cells in the bone marrow and peripheral…”
Get full text

PREDICTIVE VALUE OF QUANTITATIVE RT-QPCR BCR::ABL1 AT DIAGNOSIS AND EUTOS SCORE FOR IMATINIB RESPONSE IN CML PATIENTS by DS Oliveira, FMCP Pessoa, FAC Silva, KMC Albuquerque, PHM Alencar, LA Gurgel, RM Ribeiro, MOM Filho, MEA Moraes, CA Moreira-Nunes

“…The primary objective was to evaluate the association between the levels of BCR::ABL1 at diagnosis (BCR0), as measured by quantitative RT-qPCR, and the EUTOS…”
Get full text

PARP1 IS DIFFERENTIALLY EXPRESSED IN BCR-ABL P190+ ALL PATIENT SAMPLES AND TARGETING PARP INHIBITION INDUCES CELL DEATH COMPARABLE TO THAT OF TYROSINE-KINASE GOLDEN STANDARD IN PRE-CLINICAL MODELS by CB Machado, WAS Ferreira, FMCP Pessoa, FAR Mell-Júnior, AD Seabra, RM Ribeiro, MO Morae-Filho, MEA Moraes, LEB Souza, CFA Moreir-Nunes

“…Objective: BCR-ABL1 p190 translocation represents a worse prognosis for acute lymphoblastic leukemia (ALL) patients, and development of new therapeutic…”
Get full text

Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial by Liao, David S, Grossi, Federico V, El Mehdi, Delphine, Gerber, Monica R, Brown, David M, Heier, Jeffrey S, Wykoff, Charles C, Singerman, Lawrence J, Abraham, Prema, Grassmann, Felix, Nuernberg, Peter, Weber, Bernhard H F, Deschatelets, Pascal, Kim, Robert Y, Chung, Carol Y, Ribeiro, Ramiro M, Hamdani, Mohamed, Rosenfeld, Philip J, Boyer, David S, Slakter, Jason S, Francois, Cedric G

“…Geographic atrophy (GA), a late stage of age-related macular degeneration (AMD), is a major cause of blindness. Even while central visual acuity remains…”
Get full text

PERFIL IMUNOFENOTÍPICO DE PACIENTES PORTADORES DE MIELOMA MÚLTIPLO ATENDIDOS NO HOSPITAL GERAL DE FORTALEZA (HGF) DE 2022 A 2024 by IV Barreto, BMD Nogueira, FMCP Pessoa, RM Ribeiro, APL Moreira, RB Gadelha, MGBF Queiroz, MOM Filho, MEA Moraes, CFAM Nunes

“…Objetivo: A imunofenotipagem de células plasmáticas malignas, obtida através citometria de fluxo, apresenta um papel fundamental no diagnóstico do mieloma…”
Get full text

ALTERAÇÕES CITOGENÉTICAS EM PACIENTES COM LEUCEMIA MIELOIDE AGUDA COM ESTRATIFICAÇÃO DE RISCO ADVERSO DO HOSPITAL GERAL DE FORTALEZA by AKC Machado, FMCP Pessoa, RB Gadelha, BMD Nogueira, DS Oliveira, RM Ribeiro, APL Moreira, RPG Vieira, MOM Filho, CA Moreira-Nunes

“…Objetivos: O European LeukemiaNet (ELN) desenvolveu um sistema de estratificação de risco para Leucemia Mieloide Aguda (LMA) fundamentado em alterações…”
Get full text

ANÁLISE DA CORRELAÇÃO ENTRE VARIÁVEIS CLÍNICAS E EXPRESSÃO GÊNICA DE WRAP53 E HTERT EM PACIENTES COM LEUCEMIA MIELOIDE AGUDA by RB Gadelha, BMD Nogueira, FMCP Pessoa, RM Ribeiro, GS Lopes, HG Martins, DF Silva, MEA Moraes, MOM Filho, CFAM Nunes

“…Objetivo: A leucemia mieloide aguda (LMA) é uma doença mieloproliferativa clonal caracterizada pelo acúmulo de células imaturas e não funcionais devido a erros…”
Get full text

Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy by Mohri, H, Perelson, A S, Tung, K, Ribeiro, R M, Ramratnam, B, Markowitz, M, Kost, R, Hurley, A, Weinberger, L, Cesar, D, Hellerstein, M K, Ho, D D

“…The mechanism of CD4(+) T cell depletion in human immunodeficiency virus (HIV)-1 infection remains controversial. Using deuterated glucose to label the DNA of…”
Get full text

Viral dynamics and response differences in HCV-infected African American and white patients treated with IFN and ribavirin by Layden-Almer, Jennifer E., Ribeiro, Ruy M., Wiley, Thelma, Perelson, Alan S., Layden, Thomas J.

“…Studies have suggested that African American patients infected with hepatitis C virus (HCV) do not respond as well to treatment with interferon (IFN) as white…”
Get full text

Analysis of hepatitis B viral load decline under potent therapy: Complex decay profiles observed by Lewin, Sharon R., Ribeiro, Ruy M., Walters, Tomos, Lau, George K., Bowden, Scott, Locarnini, Stephen, Perelson, Alan S.

“…We used a new real-time polymerase chain reaction (PCR)-based assay that is sensitive, has a wide dynamic linear range, and is highly reproducible to quantify…”
Get full text

In vivo Dynamics of T Cell Activation, Proliferation, and Death in HIV-1 Infection: Why Are CD4+but Not CD8+T Cells Depleted? by Ribeiro, Ruy M., Mohri, Hiroshi, Ho, David D., Perelson, Alan S.

“…Deuterated glucose labeling was used to measure the in vivo turnover of T lymphocytes. A realistic T cell kinetic model, with populations of resting and…”
Get full text

Kinetics of Virus-Specific CD8+ T Cells and the Control of Human Immunodeficiency Virus Infection by DAVENPORT, Miles P, RIBEIRO, Ruy M, PERELSON, Alan S

“…Article Usage Stats Services JVI Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text

Production of Resistant HIV Mutants during Antiretroviral Therapy by Ribeiro, Ruy M., Bonhoeffer, Sebastian

“…HIV drug therapy often fails because of the appearance of multidrug-resistant virus. There are two possible scenarios for the outgrowth of multidrug-resistant…”
Get full text